MDT

90.28

+1.24%↑

VEEV

276.33

-1.28%↓

A

115.33

+1.47%↑

WBA

11.5

-0.17%↓

HQY

97.93

+0.06%↑

MDT

90.28

+1.24%↑

VEEV

276.33

-1.28%↓

A

115.33

+1.47%↑

WBA

11.5

-0.17%↓

HQY

97.93

+0.06%↑

MDT

90.28

+1.24%↑

VEEV

276.33

-1.28%↓

A

115.33

+1.47%↑

WBA

11.5

-0.17%↓

HQY

97.93

+0.06%↑

MDT

90.28

+1.24%↑

VEEV

276.33

-1.28%↓

A

115.33

+1.47%↑

WBA

11.5

-0.17%↓

HQY

97.93

+0.06%↑

MDT

90.28

+1.24%↑

VEEV

276.33

-1.28%↓

A

115.33

+1.47%↑

WBA

11.5

-0.17%↓

HQY

97.93

+0.06%↑

Search

Geron Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

1.29

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1.26

Max

1.32

Pagrindiniai rodikliai

By Trading Economics

Pajamos

5.5M

-20M

Pardavimai

-7.9M

40M

Pelno marža

-50.085

Darbuotojai

229

EBITDA

-375K

-17M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+181.89% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-833M

853M

Ankstesnė atidarymo kaina

1.29

Ankstesnė uždarymo kaina

1.29

Naujienos nuotaikos

By Acuity

32%

68%

97 / 376 reitingas Healthcare

Geron Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-17 23:34; UTC

Įsigijimai, susijungimai, perėmimai

FTC Reopens Consent Orders for Proposed Acquisitions from Exxon Mobil, Chevron

2025-07-17 21:14; UTC

Įsigijimai, susijungimai, perėmimai

Basel Medical Group Puts $1 Billion Bitcoin Purchase on Hold

2025-07-17 21:04; UTC

Pagrindinės rinkos jėgos
Įsigijimai, susijungimai, perėmimai

Norfolk Southern Shares Rise on WSJ Report of Union Pacific Acquisition Interest

2025-07-17 23:43; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Position Adjustments -- Market Talk

2025-07-17 23:42; UTC

Rinkos pokalbiai

Nikkei May Rise on Signs of U.S. Econ Strength -- Market Talk

2025-07-17 22:47; UTC

Įsigijimai, susijungimai, perėmimai

FTC: Maintaining Restrictions for Former Pioneer CEO Scott Sheffield Would Damage FTC's Credibility

2025-07-17 22:46; UTC

Įsigijimai, susijungimai, perėmimai

Potential Rail Merger Could Prompt Berkshire Hathaway to Bid for CSX -- Barrons.com

2025-07-17 22:46; UTC

Įsigijimai, susijungimai, perėmimai

FTC Also Says Exxon Order Disregarded Guidelines and Precedent

2025-07-17 22:43; UTC

Įsigijimai, susijungimai, perėmimai

FTC: Maintaining Restrictions on John Hess's Employment Would 'Damage the FTC's Credibility'

2025-07-17 22:43; UTC

Įsigijimai, susijungimai, perėmimai

FTC: Chevron Order Disregarded FTC Merger Guidelines and Decades of Precedent

2025-07-17 22:40; UTC

Įsigijimai, susijungimai, perėmimai

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

2025-07-17 22:40; UTC

Įsigijimai, susijungimai, perėmimai

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

2025-07-17 22:30; UTC

Rinkos pokalbiai
Uždarbis

Netflix Sticks to Its Playbook as Competitive Landscape Changes -- Market Talk

2025-07-17 22:20; UTC

Rinkos pokalbiai
Uždarbis

Global Equities Roundup: Market Talk

2025-07-17 22:20; UTC

Rinkos pokalbiai
Uždarbis

Netflix Focusing Resources on TV Viewers It Hasn't Yet Captured -- Market Talk

2025-07-17 22:04; UTC

Rinkos pokalbiai
Uždarbis

Netflix Redesign Done to Match Current Capabilities -- Market Talk

2025-07-17 22:03; UTC

Įsigijimai, susijungimai, perėmimai

China Threatens to Block Panama Ports Deal Unless Its Shipping Giant Is Part of It -- 2nd Update

2025-07-17 21:58; UTC

Rinkos pokalbiai
Uždarbis

Netflix Internal Data Doesn't Indicate Weaker Consumer Sentiment -- Market Talk

2025-07-17 21:57; UTC

Uždarbis

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

2025-07-17 21:47; UTC

Uždarbis

Netflix Raises Revenue, Margin Forecasts After Strong Second Quarter -- Update

2025-07-17 21:45; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-17 21:45; UTC

Rinkos pokalbiai

Crypto Bills Welcomed by Venture Capital, Trade Group Says -- Market Talk

2025-07-17 21:38; UTC

Įsigijimai, susijungimai, perėmimai

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- 2nd Update

2025-07-17 21:22; UTC

Įsigijimai, susijungimai, perėmimai

Update: Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

2025-07-17 21:05; UTC

Uždarbis

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

2025-07-17 21:04; UTC

Įsigijimai, susijungimai, perėmimai

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- Update

2025-07-17 21:02; UTC

Įsigijimai, susijungimai, perėmimai

Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

2025-07-17 20:59; UTC

Įsigijimai, susijungimai, perėmimai

Basel Medical Group Puts $1B Bitcoin Purchase on Hold

2025-07-17 20:50; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-07-17 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Geron Corp Prognozė

Kainos tikslas

By TipRanks

181.89% į viršų

12 mėnesių prognozė

Vidutinis 3.58 USD  181.89%

Aukščiausias 6 USD

Žemiausias 1 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Geron Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

8 ratings

5

Pirkti

2

Laikyti

1

Parduoti

Rinkos nuotaikos

By Acuity

97 / 376 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.